AZ is also waiting for a verdict in Japan before the end of the year, and in China in the first half of 2022. The approval comes on the back of the DAPA-CKD trial, which found that adding Forxiga ...
Forxiga has been approved as an adjunct to insulin ... as an adjunct to diet and exercise. Farxiga is AZ’s fifth biggest selling drug, making up around 7% of product sales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback